Intervention

rituximab

ClinicalTrials.gov intervention label

Clinical trials24
Recruiting1
Common conditions20
Lead sponsors shown15

Clinical trials

24 shown
Immunotherapy of the Recent-onset Type 1 Diabetes in Adolescents With Repeated Courses of RituximabNCT07041268 · 2024-04-19
RECRUITING
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic SclerosisNCT06655896 · 2024-10-29
ACTIVE_NOT_RECRUITING
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical ProstatectomyNCT01804712 · 2013-07-01
COMPLETED
Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid ArthritisNCT01534884 · 2012-02-01
COMPLETED
A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid ArthritisNCT01382940 · 2011-07-26
COMPLETED
A Study Of PF-05082566 As A Single Agent And In Combination With RituximabNCT01307267 · 2011-06-21
COMPLETED
Immune Intervention With Rituximab to Preserve Beta Cell Function in Early Onset Type 1 DiabetesNCT01280682 · 2010-07-01
COMPLETED
Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)NCT00147966 · 2008-06-01
COMPLETED
Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantNCT00617929 · 2008-01-01
TERMINATED
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies.NCT00462345 · 2007-06-01
COMPLETED
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's LymphomaNCT00392834 · 2006-09-01
COMPLETED
SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa TherapyNCT01126541 · 2006-09-01
COMPLETED
A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET)NCT01272908 · 2006-07-18
COMPLETED
An Analysis of Peripheral Blood T Cell Subsets on Rheumatoid ArthritisNCT00555542 · 2006-07-01
COMPLETED
A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background MethotrexateNCT00266227 · 2006-01-01
COMPLETED
A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid ArthritisNCT00299104 · 2006-01-01
COMPLETED
A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple SclerosisNCT00097188 · 2004-12-01
COMPLETED
Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University HospitalNCT00854321 · 2004-11-01
COMPLETED
A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple SclerosisNCT00087529 · 2004-06-01
COMPLETED
Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid ArthritisNCT00074438 · 2003-06-01
COMPLETED
Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaNCT00049036 · 2003-03-01
COMPLETED
Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's LymphomaNCT00031902 · 2001-10-01
UNKNOWN
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's LymphomaNCT00003595 · 1999-01-01
COMPLETED
Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's LymphomaNCT00126243 · 1999-01-01
TERMINATED

Common conditions

Rheumatoid Arthritis11Lymphoma3Multiple Sclerosis2AIDS Related Lymphoma1AIDS-related Diffuse Large Cell Lymphoma1AIDS-related Immunoblastic Large Cell Lymphoma1AIDS-related Peripheral/Systemic Lymphoma1AIDS-related Small Noncleaved Cell Lymphoma1Cancer1Carcinoma, Non-Small-Cell Lung1Carcinoma, Renal Cell1Carcinoma, Squamous Cell of Head and Neck1Diabetes Mellitus, Type 11Lymphoma, Follicular1Lymphoma, Large B-Cell, Diffuse1Lymphoma, Non-Hodgkin1Malignant Melanoma1Prostate Cancer1Scleroderma, Diffuse1Type 1 Diabetes1

Trial status mix

COMPLETED19
TERMINATED2
ACTIVE_NOT_RECRUITING1
RECRUITING1
UNKNOWN1

Phase mix

PHASE211
PHASE36
PHASE13
PHASE43
EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.